Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged pharma · clear
As an introduction to this topic, please reread my post of July 5, 2017 about The Cleveland Clinic v. True Health Diagnostics, subtitled “Time to Redefine ‘Inventive Concept'”? The claim were directed to diagnosing the presence of…
Written by Kerry S. Taylor, Ph.D. and Nathanael Luman, Ph.D. The PTAB issued a Final Written Decision upholding Pozen’s ulcer reducing Vimovo® claims based on unexpected results in Coalition For Affordable Drugs VII LLC v. Pozen Inc.,…
By Barry Herman By now, most everyone in the patent community has heard about the $2.54 Billion dollar jury verdict in a battle over Hepatitis C medication that resulted from a jury trial in December 2016. In Delaware federal district court, Idenix…
Currently there are two competing patent reform bills making the rounds in Congress: Representative Goodlatte’s Innovation Act of 2015 and the Strong Patent Act of 2015 proposed by Senator Coons. These two bills have been drawing heated debate in…
.jpg)
BRUSSELS (Reuters) - Belgian biotech firm Ablynx said on Friday that it had regained the rights for its TNF-Alpha targeting nanobodies from Pfizer, which form the basis of a rheumatoid arthritis drug currently undergoing clinical trials. Pfizer said it…
LONDON (Reuters) - Britain's highest court upheld a patent on Wednesday on a gene sequence held by Human Genome Sciences related to its new lupus drug Benlysta, in a defeat for rival drugmaker Eli Lilly. The UK Supreme Court ruling chimes with similar…
